NO20083751L - Metoder for behandling av kognitive og andre sykdommer - Google Patents
Metoder for behandling av kognitive og andre sykdommerInfo
- Publication number
- NO20083751L NO20083751L NO20083751A NO20083751A NO20083751L NO 20083751 L NO20083751 L NO 20083751L NO 20083751 A NO20083751 A NO 20083751A NO 20083751 A NO20083751 A NO 20083751A NO 20083751 L NO20083751 L NO 20083751L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- cognitive
- methods
- diseases
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78565406P | 2006-03-24 | 2006-03-24 | |
US85127806P | 2006-10-12 | 2006-10-12 | |
PCT/US2007/007209 WO2007111982A2 (en) | 2006-03-24 | 2007-03-23 | Methods for treating cognitive and other disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083751L true NO20083751L (no) | 2008-10-20 |
Family
ID=38235219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083751A NO20083751L (no) | 2006-03-24 | 2008-09-01 | Metoder for behandling av kognitive og andre sykdommer |
Country Status (18)
Country | Link |
---|---|
US (1) | US20070225278A1 (ru) |
EP (1) | EP2015749A2 (ru) |
JP (1) | JP2009531431A (ru) |
KR (1) | KR20080105105A (ru) |
AR (1) | AR060088A1 (ru) |
AU (1) | AU2007229491A1 (ru) |
BR (1) | BRPI0709146A2 (ru) |
CA (1) | CA2644618A1 (ru) |
CL (1) | CL2007000773A1 (ru) |
EC (1) | ECSP088764A (ru) |
IL (1) | IL193697A0 (ru) |
MX (1) | MX2008012208A (ru) |
NO (1) | NO20083751L (ru) |
PA (1) | PA8720401A1 (ru) |
PE (1) | PE20080126A1 (ru) |
RU (1) | RU2008135115A (ru) |
TW (1) | TW200806297A (ru) |
WO (1) | WO2007111982A2 (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200635926A (en) * | 2004-11-05 | 2006-10-16 | Wyeth Corp | Metabolites of ceratin [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof |
GT200500317A (es) * | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
AR051946A1 (es) * | 2004-11-05 | 2007-02-21 | Wyeth Corp | Formulaciones de derivados de [1,4] diazepina [6,7,1-ij] quinolina |
AR054849A1 (es) * | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
TW200734334A (en) * | 2006-01-13 | 2007-09-16 | Wyeth Corp | Treatment of substance abuse |
BRPI0709163A2 (pt) * | 2006-03-24 | 2011-06-28 | Wyeth Corp | tratamento da dor |
RU2008135326A (ru) * | 2006-03-24 | 2010-04-27 | Вайет (Us) | Терапевтические композиции для лечения депрессии |
AU2007230891A1 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | Methods for modulating bladder function |
CL2008002777A1 (es) * | 2007-09-21 | 2010-01-22 | Wyeth Corp | Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario. |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3158619A (en) * | 1962-06-14 | 1964-11-24 | Searle & Co | Certain sulfur-containing ortho-fused polycyclic pyrazole derivatives |
US3235564A (en) * | 1964-03-27 | 1966-02-15 | Searle & Co | Intermediates to certain sulfur-containing ortho-fused polycyclic pyrazole derivatives |
US3335134A (en) * | 1964-04-02 | 1967-08-08 | Sandoz Ag | Certain 3, 4-dihydrofluoreno[1, 9a, 9-e, f]1, 4-diazepin-3(2h)-ones |
US3296252A (en) * | 1964-04-02 | 1967-01-03 | Sandoz Ag | Tetracyclic diazepinone compounds |
GB1120461A (en) * | 1964-07-06 | 1968-07-17 | Manuf Prod Pharma | Derivatives of fluoreno-[1,9-ef]1,4-diazepine-1-oxide |
US3329676A (en) * | 1964-11-09 | 1967-07-04 | American Home Prod | Fused 1, 4-diazepine ring systems |
US3417101A (en) * | 1964-11-09 | 1968-12-17 | American Home Prod | Fused ring compounds |
US3714149A (en) * | 1969-11-03 | 1973-01-30 | Upjohn Co | Pyridobenzodiazepinones |
US3914250A (en) * | 1974-08-01 | 1975-10-21 | American Home Prod | 1,4-Diazepino{8 6,5,4-jk{9 carbazoles |
US4880814A (en) * | 1987-11-13 | 1989-11-14 | Abbott Laboratories | 7-cycloalkyl naphthyridines |
GB8812636D0 (en) * | 1988-05-27 | 1988-06-29 | Glaxo Group Ltd | Chemical compounds |
US4997831A (en) * | 1988-09-01 | 1991-03-05 | Glaxo Group Limited | Lactam derivatives |
US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
US5565483A (en) * | 1995-06-07 | 1996-10-15 | Bristol-Myers Squibb Company | 3-substituted oxindole derivatives as potassium channel modulators |
NZ314105A (en) * | 1996-02-02 | 1997-12-19 | Sumitomo Pharma | Guanidine derivative substituted with a substituted indole which is peri condensed with a heterocyclic ring |
GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
US6031098A (en) * | 1997-08-11 | 2000-02-29 | California Institute Of Technology | Detection and treatment of duplex polynucleotide damage |
EP1844769A3 (en) * | 1998-04-14 | 2010-02-10 | The General Hospital Corporation | Methods for treating neuropsychiatric disorders |
CO5210925A1 (es) * | 1998-11-17 | 2002-10-30 | Novartis Ag | Derivados de diamino nitroguanidina tetrasustituidos |
AR031199A1 (es) * | 2000-11-03 | 2003-09-10 | Wyeth Corp | Ciclohepta/b//1,4/diacepino/6,7,1-hi/indoles y derivados |
AR031201A1 (es) * | 2000-11-03 | 2003-09-10 | Wyeth Corp | /1,4/diazepino/6,7,1-jk/carbazoles y derivados |
WO2002036596A2 (en) * | 2000-11-03 | 2002-05-10 | Wyeth | CYCLOALKYL[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES |
US6414144B1 (en) * | 2000-11-03 | 2002-07-02 | Wyeth | Process for preparation of cyclopenta[b][1,4]diazepino[6,7,1-hi] indole derivatives |
US6916922B2 (en) * | 2000-11-03 | 2005-07-12 | Wyeth | Process for the preparation of 1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta [B] [1,4] diazepino- [6,7,1-hi] indole derivatives |
AR031200A1 (es) * | 2000-11-03 | 2003-09-10 | Wyeth Corp | Cicloocta [b] [1,4] diazepino [6,7,1-hi] indoles y derivados |
US6777407B2 (en) * | 2000-11-03 | 2004-08-17 | Wyeth | Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
PL366233A1 (en) * | 2000-12-20 | 2005-01-24 | Bristol-Myers Squibb Company | Substituted pyridoindoles as serotonin agonists and antagonists |
US6849619B2 (en) * | 2000-12-20 | 2005-02-01 | Bristol-Myers Squibb Company | Substituted pyridoindoles as serotonin agonists and antagonists |
AU2002338333A1 (en) * | 2001-04-04 | 2002-10-21 | Wyeth | Methods for treating hyperactive gastric motility |
EP1414826A1 (en) * | 2001-08-06 | 2004-05-06 | PHARMACIA & UPJOHN COMPANY | Therapeutically useful tetracyclic ligands |
MXPA04003594A (es) * | 2001-10-18 | 2004-07-30 | Upjohn Co | Azaindoles e indolinas tetraciclicas que tienen actividad en serotonina 5-ht-2. |
TW200307540A (en) * | 2002-04-25 | 2003-12-16 | Wyeth Corp | [1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents |
TWI312781B (en) * | 2002-04-25 | 2009-08-01 | [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents | |
TW200307682A (en) * | 2002-04-25 | 2003-12-16 | Wyeth Corp | 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
US20040235856A1 (en) * | 2003-04-25 | 2004-11-25 | Pfizer Inc | Treatment of incontinence |
GT200500317A (es) * | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
TW200635926A (en) * | 2004-11-05 | 2006-10-16 | Wyeth Corp | Metabolites of ceratin [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof |
AR051946A1 (es) * | 2004-11-05 | 2007-02-21 | Wyeth Corp | Formulaciones de derivados de [1,4] diazepina [6,7,1-ij] quinolina |
AR054849A1 (es) * | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
AR056695A1 (es) * | 2005-10-17 | 2007-10-17 | Wyeth Corp | Tetrahidroquinolinas, su sintesis e intermediarios |
TW200734334A (en) * | 2006-01-13 | 2007-09-16 | Wyeth Corp | Treatment of substance abuse |
BRPI0709163A2 (pt) * | 2006-03-24 | 2011-06-28 | Wyeth Corp | tratamento da dor |
MX2008012093A (es) * | 2006-03-24 | 2008-10-03 | Wyeth Corp | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de trastornos psicoticos. |
RU2008135326A (ru) * | 2006-03-24 | 2010-04-27 | Вайет (Us) | Терапевтические композиции для лечения депрессии |
CL2008002777A1 (es) * | 2007-09-21 | 2010-01-22 | Wyeth Corp | Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario. |
-
2007
- 2007-03-23 RU RU2008135115/14A patent/RU2008135115A/ru unknown
- 2007-03-23 KR KR1020087023339A patent/KR20080105105A/ko not_active Application Discontinuation
- 2007-03-23 TW TW096110126A patent/TW200806297A/zh unknown
- 2007-03-23 EP EP07753807A patent/EP2015749A2/en not_active Withdrawn
- 2007-03-23 CL CL2007000773A patent/CL2007000773A1/es unknown
- 2007-03-23 CA CA002644618A patent/CA2644618A1/en not_active Abandoned
- 2007-03-23 JP JP2009502880A patent/JP2009531431A/ja not_active Withdrawn
- 2007-03-23 PE PE2007000325A patent/PE20080126A1/es not_active Application Discontinuation
- 2007-03-23 AU AU2007229491A patent/AU2007229491A1/en not_active Abandoned
- 2007-03-23 US US11/726,924 patent/US20070225278A1/en not_active Abandoned
- 2007-03-23 AR ARP070101210A patent/AR060088A1/es unknown
- 2007-03-23 BR BRPI0709146-0A patent/BRPI0709146A2/pt not_active Application Discontinuation
- 2007-03-23 PA PA20078720401A patent/PA8720401A1/es unknown
- 2007-03-23 WO PCT/US2007/007209 patent/WO2007111982A2/en active Application Filing
- 2007-03-23 MX MX2008012208A patent/MX2008012208A/es not_active Application Discontinuation
-
2008
- 2008-08-26 IL IL193697A patent/IL193697A0/en unknown
- 2008-09-01 NO NO20083751A patent/NO20083751L/no not_active Application Discontinuation
- 2008-09-23 EC EC2008008764A patent/ECSP088764A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2015749A2 (en) | 2009-01-21 |
MX2008012208A (es) | 2008-10-02 |
JP2009531431A (ja) | 2009-09-03 |
RU2008135115A (ru) | 2010-04-27 |
CA2644618A1 (en) | 2007-10-04 |
IL193697A0 (en) | 2009-08-03 |
CL2007000773A1 (es) | 2008-01-25 |
KR20080105105A (ko) | 2008-12-03 |
PA8720401A1 (es) | 2008-12-18 |
AR060088A1 (es) | 2008-05-21 |
PE20080126A1 (es) | 2008-04-07 |
BRPI0709146A2 (pt) | 2011-06-28 |
US20070225278A1 (en) | 2007-09-27 |
WO2007111982A2 (en) | 2007-10-04 |
AU2007229491A1 (en) | 2007-10-04 |
TW200806297A (en) | 2008-02-01 |
ECSP088764A (es) | 2008-10-31 |
WO2007111982A3 (en) | 2007-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20083751L (no) | Metoder for behandling av kognitive og andre sykdommer | |
NO20076413L (no) | Multisykliske forbindelser og fremgangsmater for deres anvendelse | |
EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
EA200900959A1 (ru) | Ингибиторы мек | |
EA201170963A1 (ru) | Ингибиторы поли(адф-рибозо)полимеразы (parp) | |
BRPI0818672A2 (pt) | 2'-fluor-2'-desoxitetra-hidrouridinas como inibidores da citidina desaminase | |
EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
EA201100138A1 (ru) | 4-феноксиметилпиперидины в качестве модуляторов активности gpr119 | |
EA200901486A1 (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ, КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR | |
NO20084878L (no) | Humanisert C-kit antistoff | |
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
NO20093009L (no) | Kondensert ring heterocykel kinase modulatorer | |
MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
EA200900983A1 (ru) | Соединения и композиции в качестве ингибиторов киназы | |
MY172151A (en) | Certain chemical entities, compositions and methods | |
UA101478C2 (ru) | Соединения, полезные как ингибиторы raf-киназы | |
EA201370208A1 (ru) | Формы рифаксимина и их применение | |
NO20084490L (no) | Nye forbindelser | |
UA109878C2 (uk) | Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти) | |
WO2008016643A3 (en) | Certain chemical entities, compositions, and methods | |
WO2007050793A3 (en) | Methods and compositions for the treatment of marfan syndrome and associated disorders | |
EA201001332A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
TNSN08400A1 (en) | Organic compounds and their uses | |
EA201200570A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
EA201001330A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |